Use of dexmedetomidine for primary sedation in a general intensive care unit.
Short
Jenni
J
Salina Regional Health Center, Salina, Kansas, USA. jeshort@srhc.com
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D015400:Clinical Nursing Research; D002985:Clinical Protocols; D016292:Procedural Sedation / Q000379:methods* / Q000451:nursing; D003422:Critical Care / Q000379:methods*; D020927:Dexmedetomidine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D006993:Hypnotics and Sedatives / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D007615:Kansas; D007902:Length of Stay / Q000706:statistics & numerical data; D008140:Lorazepam / Q000627:therapeutic use; D008874:Midazolam / Q000627:therapeutic use; D009730:Nursing Assessment / Q000379:methods; D015742:Propofol / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000009:adverse effects / Q000451:nursing / Q000706:statistics & numerical data; D012449:Safety; D016896:Treatment Outcome
D000316:Adrenergic alpha-Agonists; D018712:Analgesics, Non-Narcotic; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D008140:Lorazepam; D008874:Midazolam; D015742:Propofol